Emmis Acquisition Corp. (EMIS)
EMISNASDAQ-GMBiotechnology: Pharmaceutical Preparations
$10.38
0.0000 (0.00%) today
Pre-market, Nov 9, 4:00 PM ET
- Market cap
- –
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $9.92 to $10.38
- Average volume
- 18.9k
- Previous close
- $10.38
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$72.0k | -$191.0k | -$165.0k | -$142.0k |
| Net income | -$47.0k | $933.0k | $973.0k | $749.0k |
News
8 latest- Stock Indexes Surge as Buyers Return to Chipmakers and AI StocksBarchart · 7 minutes ago
- Why Is SanDisk Stock Crashing, and is it a Generational Buying Opportunity? The Motley Fool · 8 minutes ago
- Chevron Is Doubling Venezuela Production. ExxonMobil Says It's Not in a Rush. Who's Right?The Motley Fool · 9 minutes ago
- Abbott Expands At-Home Respiratory Testing With Panbio COVID-19/Flu Self-Test; Stock Up RTTNews · 11 minutes ago
- Mirum Pharmaceuticals' Brelovitug Meets Primary Endpoint In Phase 3 AZURE-4 Study RTTNews · 14 minutes ago
- Qualcomm vs. Western Digital: Which Tech Stock Is a Better Buy for 2027?The Motley Fool · 14 minutes ago
- PRA Group: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 15 minutes ago
- Cantor Fitzgerald Initiates Coverage of Amer Sports at OverweightFintel · 18 minutes ago
The company
Emmis Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target, and it has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It may pursue an initial business combination in any business or industry. The Company will not generate any operating revenue until after the completion of a business combination.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- emmisacquisition.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.